Previous Close | 4.4500 |
Open | 4.4400 |
Bid | 4.5200 x N/A |
Ask | 4.5400 x N/A |
Day's Range | 4.4400 - 4.5800 |
52 Week Range | 3.4100 - 5.0500 |
Volume | |
Avg. Volume | 592,147 |
Market Cap | 1.128B |
Beta (5Y Monthly) | 1.20 |
PE Ratio (TTM) | 7.95 |
EPS (TTM) | 0.5700 |
Earnings Date | Nov 12, 2024 - Nov 18, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.61 |
Announced the publication of the final report from the AI Scribe Evaluation Study, conducted by OntarioMD. ...
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on tech-enabling healthcare providers, is pleased to announce the publication of the final report from the AI Scribe Evaluation Study, conducted by OntarioMD. The study highlights the effectiveness of AI-powered scribe technology in significantly reducing administrative burdens on primary care providers (PCPs) while improving both patient care and physician work-life balance.
Cantech announces its lineup of presenting companies for the 2024 Cantech Letter Investment Conference taking place on October 9, 2024 at the Arcadian Loft in Toronto, ONIn addition, Cantech is hosting several networking events including: TSX Cantech Welcome Reception, Cantech Conference Closing Reception, and El Mocambo After-PartyVancouver, British Columbia & Toronto, Ontario--(Newsfile Corp. - October 1, 2024) - Cantech Letter (the "Company" or "Cantech"), a Canadian online publication of tec